VanEck Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.42M	Sell	19,450 -456	-2%	-$131K	﹤0.01%	786
2025 Q4	$6.03M	Sell	19,906 -16,648	-46%	-$5.19M	0.01%	728
2025 Q3	$10.3M	Sell	36,554 -3,700	-9%	-$1.01M	0.01%	537
2025 Q2	$9.71M	Sell	40,254 -556,476	-93%	-$132M	0.01%	494
2025 Q1	$145M	Sell	596,730 -126,741	-18%	-$38.1M	0.19%	117
2024 Q4	$238M	Sell	723,471 -580,281	-45%	-$197M	0.3%	82
2024 Q3	$437M	Buy	1,303,752 +644,530	+98%	+$205M	0.55%	44
2024 Q2	$180M	Buy	+659,222	New	+$192M	0.26%	102
2022 Q3	–	Sell	-1,813	Closed	-$897K	–	1388
2022 Q2	$897K	Sell	1,813 -201	-10%	-$105K	﹤0.01%	813
2022 Q1	$1.13M	Buy	2,014 +525	+35%	+$316K	﹤0.01%	811
2021 Q4	$1.13M	Buy	1,489 +232	+18%	+$174K	﹤0.01%	825
2021 Q3	$938K	Buy	1,257 +88	+8%	+$65.9K	﹤0.01%	821
2021 Q2	$753K	Buy	1,169 +47	+4%	+$28.6K	﹤0.01%	848
2021 Q1	$641K	Buy	1,122 +48	+4%	+$28.4K	﹤0.01%	817
2020 Q4	$626K	Buy	1,074 +716	+200%	+$408K	﹤0.01%	750
2020 Q3	$185K	Buy	+358	New	+$181K	﹤0.01%	828